Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness.
Cancers (Basel). 2021 Sep 24;13(19):4778. doi: 10.3390/cancers13194778.
Cancers (Basel). 2021.
PMID: 34638263
Free PMC article.
Review.
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment.
Koschorke A, Faraci S, Giani D, Chiodoni C, Iorio E, Canese R, Colombo MP, Lamolinara A, Iezzi M, Ladomery M, Vernieri C, de Braud F, Di Nicola M, Tagliabue E, Castagnoli L, Pupa SM.
Koschorke A, et al.
Cell Oncol (Dordr). 2019 Dec;42(6):815-828. doi: 10.1007/s13402-019-00464-w. Epub 2019 Aug 2.
Cell Oncol (Dordr). 2019.
PMID: 31376137
Item in Clipboard
The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?
Castagnoli L, Ladomery M, Tagliabue E, Pupa SM.
Castagnoli L, et al.
Cancers (Basel). 2019 Jun 28;11(7):902. doi: 10.3390/cancers11070902.
Cancers (Basel). 2019.
PMID: 31261614
Free PMC article.
Review.
Item in Clipboard
Cite
Cite